GlobalData predicts that six late-stage pipeline products are set to enter the glaucoma market during the forecast period.

The rates at which ganglion cell-inner plexiform layer (GCIPL) and retinal nerve fiber layer (RNFL) thin in the eyes was ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

More than 4.2 million Americans live with glaucoma, a leading cause of vision loss in the nation. Although there is no cure for glaucoma, early detection and treatment can stop this condition in its ...

Some people have labeled glaucoma as the quiet disease, until it steals your vision, and then there are symptoms. In this ...

A Belfast man with limited vision is taking on his biggest challenge yet – to raise funds for the treatment of glaucoma in ...

ND02 is under clinical development by HK inno.N and currently in Phase II for Glaucoma. According to GlobalData, Phase II drugs for Glaucoma have a 39% phase transition success rate (PTSR) indication ...

Artificial intelligence-enabled discovery of a RIPK3 inhibitor with neuroprotective effects in an acute glaucoma mouse model ...

Glaucoma is a progressive eye disorder characterized by fluid buildup inside the eye, causing ocular hypertension. By 2040, ...

For the second year in a row, Bausch + Lomb has joined with the Glaucoma Research Foundation to launch the “Faces of Glaucoma ...

Glaucoma patients show slower visual response times, indicating impaired visual signal processing rather than motor or ...